Gallicchio earned his Ph.D. in Experimental Hematology at New York University Medical Center and completed fellowships in hematology at the Sloan Kettering Institute for Cancer Research and at the University of Connecticut Health Center. He was awarded a diploma in internal medicine from the “Vasile Goldis” University of Arad (Romania). He has served on the faculty at Yale University School of Medicine, University of Kentucky Medical Center, University of Central Lancashire (England), and University of Wolverhampton (England). He has served as President of Alpha Eta Honor Society, the International Society for Lithium Research, International Federation of Biomedical Laboratory Science and currently serves as Vice President of the Educational and Research Centers in Trace Elements operated under the auspice of UNESCO. He is a Fellow of the Association of Clinical Scientists, the Association of Schools of Allied Health Professions, and the Royal Society of the Arts. In 2003, at a 200th anniversary RSA event, because of his long-standing effort to educate and train biomedical laboratory science students from England, Dr. Gallicchio was recognized for his efforts by being presented to Her Majesty, Queen Elizabeth II. Dr. Vincent S. Gallicchio has 45 years experience in academic medicine and research covering experimental hematology, immunology, stem cell biology, and developmental therapeutics for human diseases such as AIDS and cancer. He has earned national and international recognition for his efforts. In a first time study reporting on academic scholarly productivity in the Journal of Clinical Laboratory Science, Dr. Gallicchio was rated the number one academic biomedical laboratory science researcher in the United States. His rating of 551 was nearly twice that of the next closest professor’s score of 285. Additionally, during his leadership, the academic program in Clinical Laboratory Science at the University of Kentucky Medical Center was rated the number one program of its kind among 127 in the nation. His passion for research, a high value placed on excellence, a strong reputation as an esteemed collaborator, and a tenacious desire to see a better therapies for human diseases brought to market speak to his overall character.
Stem cell biology, Alternative non-psychiatric medical applications of lithum, Preclinical drug pharmacology for AIDS and cancer
Dr. Woodring E. Wright received his BA degree, Summa Cum Laude, from Harvard University in 1970, a PhD under the direction of Dr. Leonard Hayflick in 1974 and an MD from Stanford University School of Medicine in 1975. Following a postdoctoral fellowship at the Pasteur Institute in Paris, France with Dr. Francois Gros, he joined the faculty at Southwestern Medical School in Dallas, Texas in 1978, where he is now Professor of Cell Biology and Southland Financial Corporation Distinguished Chair in Geriatric Research. He has been the recipient of the Lyndon Baines Johnson Research Award of the American Heart Association, a Research Career Development award from the NIH, a Merit Award from the National Institute on Aging, an AlliedSignal Award for Research on Aging, the Hayflick Award from American Aging Association and an Ellison Medical Foundation Senior Scholar Award. He is on the Scientific Advisory Board of the Buck Institute on Aging. He is the author of more than 200 scientific publications, and holds fifteen U.S. patents, with an additional eight pending.
Biology of aging and cancer, Cell and molecular analysis of muscle cell differentiation, Telomeres and telomerases
Bekir Cinar completed his Postdoctoral Fellowship, Boston Children’s Hospital, Harvard Medical School (HMS), Boston, MA (2002-2006) and Ph.D. from Department of Biochemistry and Molecular Genetics, School of Medicine University of Virginia, Charlottesville, VA (1995-2002), D.V.M., Veterinary Medical School, Ankara University, Ankara, Turkey (1987-1992). Currently he is working as Associate Professor, Department of Biological Sciences, Clark Atlanta University (CAU), Atlanta, GA 2015 to present. Presently, He is also member of the Center for Cancer Research and Therapeutic Development at CAU and a member of the NCI-designated Winship Comprehensive Cancer Center at Emory University. Prior to joining CAU, Dr. Cinar was Assistant Professor of Medicine-Hematology/Oncology and Biomedical Sciences at Cedars-Sinai Medical Center, where he was a member of Samuel Oschin Comprehensive Cancer Institute.
Biology of aging and cancer, Cell and molecular analysis of muscle cell differentiation, Telomeres and telomerase
Segundo Mesa Castillo is a Specialist in Neurology; he has worked for 10 years in the Institute of Neurology of Havana, Cuba. He has worked with Electron Microscopy on Schizophrenia for 32 years. He was awarded with the International Price of the Stanley Foundation Award Program and for the Professional Committee to work as a fellowship position in the Laboratory of the Central Nervous System Studies, National Institute of Neurological Diseases and Stroke under Dr. Joseph Gibbs for a period of 6 months, National Institute of Health, Bethesda, Washington DC USA.
Neurology, Psychiatry, Neurological Diseases. Stroke
Dr. Feng Tao is an Associate Professor in the Department of Biomedical Sciences at Texas A&M University College of Dentistry. Dr. Tao received his RO1 award and Independent Scientist Award from NIH in 2012 and 2014, respectively. He has published more than 40 papers in peer-reviewed professional journals and he is serving as an editorial board member for some professional journals. Dr. Tao also served as an invited reviewer for NIH NRCS Study Section, Johns Hopkins ACCM Seed Grant, NSF-sponsored Pilot Funding at Louisiana State University, Arizona Biomedical Research Commission, Britain Israel Research and Academic Exchange Partnership Regenerative Medicine Initiative, Wings for Life?Spinal Cord Research Foundation in Austria, Department of Veterans Affairs Rehabilitation Research and Development Service Spinal Cord Injury and Neuropathic Pain Panel, and The French National Research Agency (ANR) in France.
His research interests focus on the central mechanisms of pain transmission and analgesia. Pain is a hallmark of tissue damage and inflammation, which promotes tissue protection and thereby contributes to repair.
Dr. Yong Li is an Associate Professor within the Center Stem Cell for Regenerative Medicine, and Center for Tissue Engineering and Aging Research at the Brown Foundation Institute of Molecular Medicine (IMM), UT Health. He also is appointed as an Associate Professor in the Department of Pediatric and Orthopedic Surgery, and Internal Medicine, UTHealth. Dr. Li accomplished his MD and Ph.D. training in China and was a general surgeon before he went to London of the United Kingdom in 1997. His first research career as a post-doctor fellow trained in Imperial College School of Medicine in the UK (1997-1999), and later as a postdoctoral research associate in Children’s Hospital of Pittsburgh of UPMC. He was promoted to a research assistant professor in 2002, assistant professor in 2004 (within a tenure-track system in 2006), and led his research team approach success in the field of adult stem cell, environmental motivation, anti-fibrosis in regeneration medicine. These projects also include the enlargement and application of adult stem cells (muscle and skin) to repair traumatic injury (muscle, tendon, spinal cord and brain) and congenital diseases. His academic career includes more than 100 peer-reviewed publications; over seven millions’ grant funding from NIH and DOD; over 50 training fellows and students; more than 28 national or international awards; over 30 times grant reviewer or panelist; service 10 journals’ editor boards; more than 50 times’ lecture in the conferences or seminars and 160 times of posters presentation in conferences.
His research in Children’s Regenerative Medicine, Dedifferentiation and Stem Cell Populations, Adult Embryonic Potential Stem Cells and Application, Fibrosis and Prevention Studies, Combination of mammalian cells with amphibian cells to investigate the potential of tissue/organ regeneration process in the Newt model and the mechanisms
Dr. M. James You completed his Ph.D from The University of Texas at Austin – 1997 and M.D. from Zhejiang University School of Medicine – 1986 and currently he is working as Associate Professor in Department of Hematopathology , The University of Texas MD Anderson Cancer Center, Houston, USA.
Our laboratory is interested in cancer biology and genetics as well as translational research. Our current focus is myeloid and lymphoid neoplasm using genetic and oncogenomic approaches to uncover important genetic events that may drive tumor initiation and progression. Approaches include Cre / Lox- and Flp / FRT-based conditional systems to generate genetically engineered mouse models, including acute leukemia, which permits studies of the underlying biology and mechanisms of various tumor types. In addition, we complement basic mechanistic studies with translational research on human tumor specimens, which helps to correlate genetic changes, expression profiling, or other molecular signatures with clinical behavior and outcome.
Mustafa Akcelik has completed his PhD at the age of 28 years from Ankara University and postdoctoral studies from California University at Davis School of Medicine. He is the Professor at the department of Biology, University of Ankara. He has published more than 100 papers in reputed journals and has been serving as an editorial board member of repute.
Molecular Genetic, Microbiology, BiotechnologyLactic acid bacteria, Salmonella pathogenicity, Genetic regulation, Biology of plasmids, Conjugation, Phage resistance, Bacteriocin production.
Prof. Namrita Lall has completed her Ph.D from the University of Pretoria and was a visiting scientist at the University of Illinois, Chicago and Kings College London. She has published more than 120 papers in reputed journals. She is also the co-inventor of 16 national and international patents. This medicinal plant scientist at the University of Pretoria is ranked in the top 1% of the global Essential Science Indicators list of influential academics who write about pharmacology and toxicology. In 2014, she received the Order of Mapungubwe - South Africa’s highest honour - from President Jacob Zuma, in recognition of her research.
Prof Lall’s main research interests include antituberculosis natural product leads from medicinal plants, susceptibility studies of other bacteria to medicinal plants, cytotoxicity of plant extracts/compounds, anticancer activity of medicinal plants, antityrosinase (skin pigmentation) activity of plants, isolation and purification of bioactive principles from plants